By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antiandrogens > Erleada > Erleada Dosage
Antiandrogens
https://themeditary.com/dosage-information/erleada-dosage-371.html

Erleada Dosage

Drug Detail:Erleada (Apalutamide [ ap-a-loot-a-mide ])

Generic Name: APALUTAMIDE 60mg

Dosage Form: tablet, film coated

Drug Class: Antiandrogens Hormones / antineoplastics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Recommended Dosage

​The recommended dose of ERLEADA is 240 mg administered orally once daily. Swallow the tablets whole. Do not crush or split tablets. ERLEADA can be taken with or without food.

Patients should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had a bilateral orchiectomy.

Dosage Modification

​If Grade 3 or greater adverse reactions, or other intolerable adverse reactions occur, withhold ERLEADA. Consider permanent discontinuation of ERLEADA for Grade 3 or 4 cerebrovascular and ischemic cardiovascular events [see Warnings and Precautions (5.1)] . Permanently discontinue ERLEADA for confirmed SCARs or for other Grade 4 skin reactions [see Warnings and Precautions (5.5) and Adverse Reactions (6.1)] . For other adverse reactions, when symptoms improve to less than or equal to Grade 1 or original grade, resume ERLEADA at the same dose or a reduced dose (180 mg or 120 mg), if warranted.

Alternate Methods of Administration

​Disperse 240 mg Tablet in Water and Administer with Orange Juice, Applesauce, or Additional Water

​For patients who cannot swallow the tablet whole, the recommended dose of one ERLEADA 240 mg tablet can be dispersed in non-carbonated water and then administered with either orange juice, applesauce, or additional water as follows:

  1. ​Place the whole ERLEADA 240 mg tablet in a cup. Do not crush or split the tablet.
  2. ​Add about 2 teaspoons (10 mL) of non-carbonated water to make sure that the tablet is completely immersed in water.
  3. ​Wait 2 minutes until the tablet is broken up and spread out, then stir the mixture.
  4. ​Add 2 tablespoons (30 mL) of either orange juice, applesauce, or additional water and stir the mixture.
  5. ​Swallow the mixture immediately.
  6. ​Rinse the cup with enough water to make sure the whole dose is taken and drink it immediately.

​Do not store ERLEADA that is mixed with non-carbonated water, orange juice, or applesauce for later use.

​Administer 240 mg Tablet Through a Feeding Tube

​ERLEADA 240 mg tablet can be administered through a feeding tube 8 French or greater as follows:

  1. ​Place one 240 mg tablet in the barrel of the syringe (use at least a 20 mL syringe) and draw up 10 mL of non-carbonated water into the syringe.
  2. ​Wait 10 minutes and then shake vigorously to disperse contents completely.
  3. ​Administer immediately through the feeding tube.
  4. ​Refill the syringe with non-carbonated water and administer. Repeat until no tablet residue is left in the syringe or feeding tube.

Administer 60 mg Tablets with Applesauce

​For patients who have difficulty swallowing tablets whole, the recommended dose of ERLEADA 60 mg tablets may be mixed in applesauce.

  1. ​Mix whole ERLEADA 60 mg tablets in 4 ounces (120 mL) of applesauce by stirring. Do not crush or split the tablets.
  2. Wait 15 minutes, stir the mixture.
  3. Wait another 15 minutes, stir the mixture until tablets are dispersed (well mixed with no chunks remaining).
  4. Using a spoon, swallow the mixture right away.
  5. Rinse the container with 2 ounces (60 mL) of water and immediately drink the contents. Repeat the rinse with 2 ounces (60 mL) of water a second time to ensure the whole dose is taken.

Consume the mixture within one hour of preparation. Do not store ERLEADA that is mixed with applesauce.

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by